00:00
So let's look at these three
compared to each other,
now we can give them in
multiple different routes,
We talked about the
inhaled powder route
for the Zanamivir,
But remember it can be given
multiple different routes too.
00:12
But we focused on the oral route
the inhaled powder
and an example of an
IV route of medication.
00:18
You've got a difference
in minimum of age.
00:21
So let's play with that
column a little bit
when I'm studying
a chart like this
either kind of
questions I ask myself.
00:26
Why would I give a oseltamivir
over one of the other two,
well if my patient was what?
Three years old,
that would be the
only option for me.
00:39
So by asking yourself questions
or if you're really
good study buddy
having them asking
you questions.
00:44
That's a really
effective way to learn.
00:47
Look at the side effects.
00:48
Look for things that are similar
and things that are different.
00:51
So we know we've
got some GI issues
kind of over the whole,
across the board, right,
but we're going to be really
careful with inhaled powder
and anyone with
known lung problems.
01:01
Now the rare adverse
effects, line, right, up.
01:05
So this is a really easy way
great cheat sheet we
have for you here.
01:09
Once you've walked through the other
parts of the video before this chart.
01:13
This one can be really helpful
because you've
already done the work
to think through these things.
01:18
We just gave you a summary
chart here towards the end.
01:22
Now I want to talk about LAIV.
01:25
That means Live Attenuated
Influenza Virus,
so these these drugs
Neuraminidase Inhibitors
can may blunt the response
a patient would have
to a live attenuated
influenza virus.
01:38
So we're going to stop
these medications.
01:40
I have full two days before
the influenza vaccine.
01:44
Okay, you want to wait two
weeks after the vaccine
before you would start these.
01:48
Also this is really important
that you ask if the patient is
taken one of these medications
before they receive an LAIV.
01:57
So great task
question wouldn't it?
Which of the questions?
His most important to ask a
patient before giving them.
02:04
This might be an option.
02:05
So keep that in mind.
02:07
If a patient is going to receive
a live attenuated
influenza virus.
02:11
They shouldn't have taken
a Neuraminidise Inhibitor
or an NI for a full two days
before they get the vaccine.
02:19
Now what's cool about this?
Hey, that's that 48 hour window.
02:23
So we know start them
within 48 Hours of symptoms
start prophylaxis within
48 Hours of exposure.
02:30
Really 12 hours was better
but 48 is the limit for that
and if they're going to
get live attenuated virus,
then we want to make sure
that they stop and ice
two days before getting them.
02:41
You've got it.
02:42
I remember wait two weeks,
There's the number two again
after vaccine to take
the medication again.